Today

Agents

Chat

Arena

Discover

More

App

Emergent BioSolutions Q2 Revenue USD 234.3 Million - EBS News | Rallies

Emergent BioSolutions Q2 Revenue USD 234.3 Million

EBS•2026-08-05

Second-quarter results

Aug. 5 (Reuters) - Emergent BioSolutions Q2 adjusted EBITDA USD 96.5 million.

Q2 net income USD -180.2 million
Q2 adjusted net income USD 30.9 million
Q2 adjusted EPS USD 0.6
Q2 gross margin 50%
Q2 adjusted gross margin 58%

Related News

Ooma to report Q2 results after market close, host investor call

OOMA•2026-08-05

Seaport Entertainment Q2 adjusted profit turns positive as expenses fall

SEG•2026-08-05

AZZ to present at Three Part Advisors Midwest Ideas Conference

2026-08-05

Curtiss-Wright Q2 EPS beats estimates as margins expand

CW•2026-08-05

Star Group Q3 net loss widens due to unfavorable derivative changes and higher expenses

SGU•2026-08-05